The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Annals of Internal Medicine

• Publication date

  2010-03-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/0003-4819-152-6-201003160-00004PMID 20231565PMCID PMC3138470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Utility of Adiponectin as a Biomarker Predictive of Glycemic Efficacy Is Demonstrated by Collaborative Pooling of Data From Clinical Trials Conducted by Multiple Sponsors

  2009cited by this paper
• Nuclear Factor-&kgr;B Activation Contributes to Vascular Endothelial Dysfunction via Oxidative Stress in Overweight/Obese Middle-Aged and Older Humans

  2009cited by this paper
• The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study

  2009cited by this paper
• Variations in DNA elucidate molecular networks that cause disease

  2008influential reference
• Uric acid and cardiovascular risk.

  2008influential reference
• Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes

  2008influential reference
• National Institute of Diabetes and Digestive and Kidney Diseases

  2008cited by this paper
• High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

  2008cited by this paper
• Salicylates increase insulin secretion in healthy obese subjects.

  2008influential reference
• Evaluation of the modification of diet in renal disease study equation in a large diverse population.

  2007influential reference
• Inflammation and metabolic disorders

  2006cited by this paper
• Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods

  2006cited by this paper
• Inflammation and insulin resistance.

  2006cited by this paper
• Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB

  2005influential reference
• IKK-β links inflammation to obesity-induced insulin resistance

  2005cited by this paper
• Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.

  2005cited by this paper
• IKK-beta links inflammation to obesity-induced insulin resistance.

  2005cited by this paper
• Inflammation and insulin resistance.

  2003cited by this paper
• Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.

  2002influential reference
• Literature Abstracts

  2001influential reference
• Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ

  2001influential reference
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.

  1998cited by this paper
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β

  1998influential reference
• Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration.

  1996cited by this paper
• Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation

  1996cited by this paper
• The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

  1995cited by this paper
• The effect of sodium salicylate and aspirin on NF-kappa B.

  1995cited by this paper
• Inhibition of NF-kappa B by sodium salicylate and aspirin.

  1994cited by this paper
• Effect of sodium salicylate on the human heat shock response.

  1992cited by this paper
• Annals of Internal Medicine

  1992cited by this paper
• Hemostatic effects of salsalate in normal subjects and patients with hemophilia A.

  1991influential reference
• Does the acetyl group of aspirin contribute to the antiinflammatory efficacy of salicylic acid in the treatment of rheumatoid arthritis?

  1990cited by this paper
• Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study.

  1990cited by this paper
• An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen.

  1989cited by this paper
• Ulcers of the small bowel associated with stomach-bypassing salicylates.

  1985cited by this paper
• Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans.

  1985cited by this paper
• Ulcers of the small bowel associated with stomach-bypassing salicylates.

  1985cited by this paper
• A Simple Sequentially Rejective Multiple Test Procedure

  1979cited by this paper
• Effects of Salicylates on the Gastric Mucosa as Revealed by Roentgen Examination and the Gastrocamera

  1971cited by this paper
• The Influence of Salicylate on Hyperglycemia

  1960cited by this paper
• Aspirin and Diabetes Mellitus

  1957influential reference
• On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate

  1901cited by this paper
• College of Physicians and Surgeons

  1886cited by this paper

• The Interplay Between Reactive Oxygen Species, Glucose Metabolism and NF-kB in the Pathogenesis of Type 2 Diabetes

  2026cites this paper
• Pharmacological advances in multi-targeted strategies for type 2 diabetes mellitus: a systematic perspective based on traditional Chinese medicine.

  2026cites this paper
• A nitroalkene derivative of salicylate, SANA, induces creatine-dependent thermogenesis and promotes weight loss

  2025cites this paper
• Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma

  2025cites this paper
• Obesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction

  2025cites this paper
• Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies

  2025cites this paper
• Lipid overload meets S-palmitoylation: a metabolic signalling nexus driving cardiovascular and heart disease

  2025cites this paper
• Role of B lymphocyte ratio in development of type 2 diabetes mellitus: results of a 7-year follow-up study.

  2025cites this paper
• Phytotherapeutic insights into hyperuricemia: a mechanistic and clinical perspective

  2025cites this paper
• Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction.

  2025cites this paper
• Unraveling the RKIP–YY1 axis: immune crosstalk in the pathogenesis of metabolic disorders

  2025cites this paper
• Inhibition of α-Amylase and α-Glucosidase Using Baccaurea ramiflora

  2025cites this paper
• Mitochondrial targeted therapies in MAFLD.

  2025cites this paper
• Inflammation and resolution in obesity

  2024cites this paper
• Safety and Efficacy of Canakinumab for the Prevention and Control of Type 2 Diabetes Mellitus and Its Complications: A Systematic Review

  2024cites this paper
• Diabetes mellitus-Progress and opportunities in the evolving epidemic.

  2024cites this paper
• Salicylate induces epithelial actin reorganization via activation of the AMP-activated protein kinase and promotes wound healing and contraction in mice

  2024cites this paper
• Drug conjugates crosslinked bioresponsive hydrogel for combination therapy of diabetic wound.

  2024cites this paper
• Implications of the cGAS-STING pathway in diabetes: Risk factors and therapeutic strategies.

  2024cites this paper
• Targeting neuroinflammation in distal symmetrical polyneuropathy in diabetes.

  2024cites this paper
• Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review

  2024cites this paper
• Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment

  2024cites this paper
• Salsalate Improves Postprandial Glycemic and Some Lipid Responses in Persons With Tetraplegia: A Randomized Clinical Pilot Trial With Crossover Design.

  2023cites this paper
• The emerging significance of mitochondrial targeted strategies in NAFLD treatment.

  2023cites this paper
• The PTGS2/COX2-PGE2 signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus

  2023cites this paper
• Salsalate and/or metformin therapy confer beneficial metabolic effects in olanzapine treated female mice.

  2023cites this paper
• Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model

  2023cites this paper
• Association between obesity, inflammation and insulin resistance: insights into signaling pathways and therapeutic interventions.

  2023cites this paper
• Effects of anti-inflammatory therapies on glycemic control in type 2 diabetes mellitus

  2023cites this paper
• Metaflammation in obesity and its therapeutic targeting

  2023cites this paper
• Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment.

  2023cites this paper
• Impact of Polyphenols on Inflammatory and Oxidative Stress Factors in Diabetes Mellitus: Nutritional Antioxidants and Their Application in Improving Antidiabetic Therapy

  2023cites this paper
• A nitroalkene derivative of salicylate alleviates diet-induced obesity by activating creatine metabolism and non-shivering thermogenesis

  2023cites this paper
• Immune cells in adipose tissue microenvironment under physiological and obese conditions

  2023cites this paper
• Salicylate Sodium Suppresses Monocyte Chemoattractant Protein-1 Production by Directly Inhibiting Phosphodiesterase 3B in TNF-α-Stimulated Adipocytes

  2022cites this paper
• The rheumatoid arthritis drug auranofin lowers leptin levels and exerts antidiabetic effects in obese mice.

  2022cites this paper
• Preparation and Characterization of Salsalate-Loaded Chitosan Nanoparticles: In Vitro Release and Antibacterial and Antibiofilm Activity

  2022cites this paper
• Relationship between Oxidative Stress and Diabetes Mellitus 1

  2022cites this paper
• The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK

  2022cites this paper
• Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes

  2022cites this paper
• Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression

  2022cites this paper
• Targeting AMPK Signaling in the Liver: Implications for Obesity and Type 2 Diabetes Mellitus.

  2022cites this paper
• Anti-tumor Necrosis Factor-Alpha Therapy and Hypoglycemia: A Real-World Pharmacovigilance Analysis

  2022cites this paper
• Flavonoids, alkaloids and terpenoids: a new hope for the treatment of diabetes mellitus

  2022cites this paper
• Inflammation in obesity, diabetes, and related disorders.

  2022cites this paper
• Alterations of CD163 expression in the complications of diabetes: A systematic review.

  2022cites this paper
• Targeting skeletal muscle mitochondrial health in obesity

  2022cites this paper
• Combining Metformin and Drug-Loaded Kidney-Targeting Micelles for Polycystic Kidney Disease

  2022cites this paper
• The pathogenic role of foam cells in atherogenesis: Do they represent novel therapeutic targets?

  2022cites this paper
• A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records

  2022cites this paper
• Chronic tissue inflammation and metabolic disease

  2021influential citation
• Cardiometabolic risks and atherosclerotic disease in ApoE knockout mice: Effect of spinal cord injury and Salsalate anti-inflammatory pharmacotherapy

  2021cites this paper
• CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys.

  2021cites this paper
• The role of autoimmunity in the pathophysiology of type 2 diabetes: Looking at the other side of the moon

  2021cites this paper
• Role of obesity-induced inflammation in the development of insulin resistance and type 2 diabetes: history of the research and remaining questions

  2021cites this paper
• Sevoflurane-induced hyperglycemia is attenuated by salsalate in obese insulin-resistant mice

  2021cites this paper
• Salsalate reduces atherosclerosis through AMPKβ1 in mice

  2021cites this paper
• Accumulation of auranofin in white adipose tissues lowers leptin levels and exerts anti-diabetic effects

  2021cites this paper
• L’inflammation dans la physiopathologie et le traitement du diabète de type 2 et de ses complications

  2021cites this paper
• Cysteine 253 of UCP1 regulates energy expenditure and sex-dependent adipose tissue inflammation.

  2021cites this paper
• Chrysin modulates protein kinase IKKε/TBK1, insulin sensitivity and hepatic fatty infiltration in diet‐induced obese mice

  2021cites this paper
• IL-25 Treatment Improves Metabolic Syndrome in High-Fat Diet and Genetic Models of Obesity

  2021cites this paper
• Novel therapies with precision mechanisms for type 2 diabetes mellitus

  2021cites this paper
• Treatment for diabetic peripheral neuropathy: What have we learned from animal models?

  2021cites this paper
• Application value of combination therapy of periodontal curettage and root planing on moderate-to-severe chronic periodontitis in patients with type 2 diabetes

  2021cites this paper
• Insulin action at a molecular level – 100 years of progress

  2021cites this paper
• DMSO_A_335761 4875..4887

  2021cites this paper
• Systems immunology

  2020cites this paper
• Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia.

  2020cites this paper
• Association of ABCA1 (C69T) gene polymorphism with dyslipidemia and type 2 diabetes among the Egyptian population

  2020cites this paper
• Protective Role of St. John’s Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies

  2020cites this paper
• STAT1 Dissociates Adipose Tissue Inflammation From Insulin Sensitivity in Obesity

  2020cites this paper
• The imidazopyridine derivative X22 prevents diabetic kidney dysfunction through inactivating NF-κB signaling.

  2020cites this paper
• Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes

  2020influential citation
• Immunometabolism in type 2 diabetes mellitus: tissue-specific interactions

  2020cites this paper
• Hypoglycaemic effect and mechanism of an RG-II type polysaccharide purified from Aconitum coreanum in diet-induced obese mice.

  2020cites this paper
• Molecular mechanism of interactions between chrysin and I-kappa-B kinase epsilon (IKKe)/tank binding kinase-1(TBK1): Cell-based assay and in silico molecular docking studies

  2020cites this paper
• Tau-based therapies for Alzheimer’s disease: Promising novel neuroprotective approaches

  2020cites this paper
• Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus

  2020cites this paper
• The metabolic response to inflammation in astrocytes is regulated by nuclear factor‐kappa B signaling

  2020cites this paper
• Lactoferrin in Aseptic and Septic Inflammation

  2019cites this paper
• Inflammation in the pathophysiology and therapy of cardiometabolic disease.

  2019cites this paper
• Title Salicylate , diflunisal and their metabolites inhibit CBP / p 300 and exhibit anticancer activity

  2019influential citation
• Nrf2 exerts mixed inflammation and glucose metabolism regulatory effects on murine RAW264.7 macrophages.

  2019cites this paper
• Immune Cells Gate White Adipose Tissue Expansion.

  2019cites this paper
• Essential Roles for the Non-Canonical IκB Kinases in Linking Inflammation to Cancer, Obesity, and Diabetes

  2019cites this paper
• Acute effects of active breaks during prolonged sitting on subcutaneous adipose tissue gene expression: an ancillary analysis of a randomised controlled trial

  2019cites this paper
• Anti‐inflammatory effects of resolvins in diabetic nephropathy: Mechanistic pathways

  2019cites this paper
• Inhibitory effects of berberine on proinflammatory M1 macrophage polarization through interfering with the interaction between TLR4 and MyD88

  2019cites this paper
• Canakinumab: Promises and Future in Cardiometabolic Diseases and Malignancy.

  2019cites this paper
• CHRONIC INTERACTION BETWEEN METFORMIN AND MELOXICAM IN MICE

  2019cites this paper
• Salicylate enhances the response of prostate cancer to radiotherapy

  2019cites this paper
• The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation

  2019cites this paper
• Salsalate Prevents β-Cell Dedifferentiation in OLETF Rats with Type 2 Diabetes through Notch1 Pathway

  2019cites this paper
• Terapias antiinflamatorias para la enfermedad cardiovascular: vías de señalización y mecanismos

  2019cites this paper
• Effect of Salicylate on Albino Rats by Study of Serum Globulin pattern

  2019cites this paper
• Anti-inflammatory therapies for cardiovascular disease: signaling pathways and mechanisms.

  2019cites this paper
• Type 2 Diabetes: How Much of an Autoimmune Disease?

  2019influential citation
• An Integrated View of Immunometabolism.

  2018influential citation
• Hypothalamic inflammation and malfunctioning glia in the pathophysiology of obesity and diabetes: Translational significance

  2018cites this paper